Physician profile
Harbir D Singh
NPI 1508844846
$1,244.39
in general payments reported to CMS, 2019-2025
16 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.39 · 2021: $192 · 2022: $279 · 2023: $315 · 2024: $155 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $339.64 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $189.40 | 2023-2024 | Gemtesa, Aptiom |
| Teva Pharmaceuticals USA, INC. | $167.09 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $159.80 | 2021-2024 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $96.98 | 2025 | Rexulti |
| Alkermes, INC. | $56.11 | 2022-2023 | Aristada, Lybalvi |
| Exact Sciences Corporation | $47.96 | 2025 | Cologuard Collection Kit |
| Lundbeck LLC | $47.49 | 2023-2025 | Rexulti |
| Amgen INC. | $31.48 | 2025 | Repatha, Otezla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.26 | 2025 | Caplyta |
| Philips North America LLC | $16.12 | 2025 | Incourage Airway Clearance Therapy |
| Bayer Healthcare Pharmaceuticals INC. | $15.43 | 2022 | |
| Eisai INC. | $14.85 | 2021 | |
| Lilly USA, LLC | $13.94 | 2025 | |
| Axsome Therapeutics, INC. | $13.45 | 2025 | Auvelity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harbir Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.